Literature DB >> 15830468

Microbiological characterization of everninomicins B and D.

W E Sanders, C C Sanders.   

Abstract

Everninomicins B and D are components of a complex of antibiotic substances produced by Micromonospora. Both were shown to be highly active inhibitors of growth of all gram-positive bacteria, Neisseria, and Bacteroides studied in vitro. Potency of activity appeared to be greater than that of chloramphenicol, but less than that of penicillin G, when assayed against strains susceptible to each of the drugs. The everninomicins were bacteriostatic for all strains tested, except group A streptococci. No facultatively anaerobic gram-negative bacilli were susceptible. Resistant mutants were selected with difficulty from susceptible staphylococci in the laboratory, and these demonstrated no cross-resistance to available antimicrobial agents. Most variations in media, growth conditions, or procedure of assay had little or no effect on antimicrobial activity. Only addition of serum or increase in inoculum size reduced antibacterial activity. Significant differences in activity of the two components were encountered infrequently; the B component was four- to sixfold more active against gonococci and group A streptococci, whereas the D component was fourfold more active against enterococci. Because of the high degree of in vitro activity and lack of resistance among susceptible genera of bacteria, the everninomicins clearly merit further careful study as potential therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15830468      PMCID: PMC444632          DOI: 10.1128/AAC.6.3.232

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Oxacillin: laboratory and clinical evaluation.

Authors:  W M KIRBY; L S ROSENFELD; J BRODIE
Journal:  JAMA       Date:  1962-09-01       Impact factor: 56.272

2.  Observations on bacteriostatic and bactericidal action of erythromycin.

Authors:  L UNGER; A KISCH
Journal:  Proc Soc Exp Biol Med       Date:  1958-05

3.  The susceptibility of gram-positive cocci gram-negative bacilli, and clostridia to terramycin.

Authors:  E A BLISS; P T WARTH; C A CHANDLER
Journal:  Ann N Y Acad Sci       Date:  1950-09       Impact factor: 5.691

4.  Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.

Authors:  C C Crowe; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

Review 5.  Lincomycin versus erythromycin: a choice or an echo.

Authors:  E Sanders
Journal:  Ann Intern Med       Date:  1969-03       Impact factor: 25.391

6.  Structure and absolute stereochemistry of everheptose.

Authors:  A K Ganguly; O Z Sarre; D Greeves; J Morton
Journal:  J Am Chem Soc       Date:  1973-02-07       Impact factor: 15.419

7.  Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.

Authors:  E Sanders; M T Foster; D Scott
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

8.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

9.  CHEMISTRY OF ANTIBIOTICS FROM MICROMONOSPORA. 3. ISOLATION AND CHARACTERIZATION OF EVERNINOMICIN D AND B.

Authors:  H L HERZOG; E MESECK; S DELORENZO; A MURAWSKI; W CHARNEY; J P ROSSELET
Journal:  Appl Microbiol       Date:  1965-07

10.  Induction, course, and transmissibility of monkeypox in the baboon (Papio cynocephalus).

Authors:  R L Heberling; S S Kalter
Journal:  J Infect Dis       Date:  1971-07       Impact factor: 5.226

  10 in total
  5 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.

Authors:  E Wang; M Simard; Y Bergeron; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

3.  Pharmacokinetics of an everninomicin (SCH 27899) in mice, rats, rabbits, and cynomolgus monkeys following intravenous administration.

Authors:  C Lin; S Gupta; D Loebenberg; M N Cayen
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

4.  Structures of the orthosomycin antibiotics avilamycin and evernimicin in complex with the bacterial 70S ribosome.

Authors:  Stefan Arenz; Manuel F Juette; Michael Graf; Fabian Nguyen; Paul Huter; Yury S Polikanov; Scott C Blanchard; Daniel N Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-21       Impact factor: 11.205

5.  De Novo Whole-Genome Sequence of Micromonospora carbonacea JXNU-1 with Broad-Spectrum Antimicrobial Activity, Isolated from Soil Samples.

Authors:  Yun Jiang; Yun-Hong Huang; Zhong-Er Long
Journal:  Genome Announc       Date:  2015-04-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.